Clinical Trial

Combined Distal Femoral Nerve Block for Pain Control After Knee Replacement

Study acronym: FEM-COMB
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to see whether a combined distal femoral nerve block improves pain relief after total knee replacement in adults having planned surgery. The main questions it aims to answer are: * Does the combined distal femoral nerve block reduce the amount of opioid needed in the post-anesthesia recovery room? * Does it preserve quadriceps muscle strength while improving postoperative pain control? Researchers will compare the combined distal femoral nerve block to a saphenous nerve block alone to see if the combined block provides better analgesia without reducing leg strength. Participants will: * Receive either the combined distal femoral nerve block or the saphenous nerve block alone before surgery. * Also receive standard multimodal pain management, including anesthesia, surgical site infiltration, and postoperative pain medications. * Be assessed for pain, opioid use, nausea and vomiting, quadriceps strength, time to first standing, hospital stay length, and patient satisfaction from surgery until discharge.
Protocol Amendment History 1 change
notable Sponsor changed: Ramsay Générale de Santé -> GCS Ramsay Santé pour l'Enseignement et la Recherche 2026-07-19
Trial Details
NCT Number NCT07629388
Lead Sponsor Ramsay Générale de Santé
Conditions Pain After Total Knee Arthroplasty, Pain Management
Enrollment 240 participants
Start Date 2026-05-25
Primary Completion 2027-05-25 (estimated)
Study Completion 2027-05-25 (estimated)
Updated on ClinicalTrials.gov 2026-06-05